Sinclair Research, a leading provider of nonclinical contract research services, today announced an agreement to acquire the assets of the GLP safety pharmacology business unit of CorDynamics, a premier provider of cardiovascular toxicology and safety pharmacology contract research services.
CorDynamics is an Illinois-based healthcare service center that provides research lab and consulting services for the treatment of cardiovascular diseases for individuals.